Lawyers representing Oklahoma are seeking up to $17 billion from J&J and its pharma subsidiary Janssen, claiming the company ran a “cunning, cynical and deceitful scheme” to encourage massive ...

Shares in J&J blipped upwards in the wake of the ruling by Judge Thad Balkman because – despite the sizeable award – Oklahoma’s attorney-general Mike Hunter had argued the company should ...